- Generic name
- Ramipril
- Strength
- 1.25 mg
- Dosage form
- Tablet
- Manufactured by
- Rangs Pharmaceuticals Ltd.
RAMPRIL 1.25 Tablet
About RAMPRIL 1.25 Tablet
Made by Rangs Pharmaceuticals Ltd., RAMPRIL 1.25 is a tablet whose active ingredient is Ramipril. Only a doctor can decide if it is appropriate for a particular person.
There are 42 brands of Ramipril listed in Bangladesh. The lowest listed price is Ramoril 1.25 mg Tablet at ৳ 2.5 per unit.
What is RAMPRIL 1.25 Tablet?
RAMPRIL 1.25 is a tablet from Rangs Pharmaceuticals Ltd., with the generic name Ramipril. It contains Ramipril, which belongs to a group of medicines called angiotensin-converting enzyme (ACE) inhibitors. It works by relaxing blood vessels, which helps lower blood pressure and makes it easier for the heart to pump blood. The doctor decides the dose and course.
Uses of RAMPRIL 1.25
Only a doctor can decide if it is appropriate for a particular person. It is also used for congestive heart failure, sometimes with a diuretic. Your doctor will confirm whether Ramipril is appropriate for your condition.
How to use RAMPRIL 1.25
Swallow the tablet with water. RAMPRIL 1.25 is taken by mouth. Take RAMPRIL 1.25 1.25 mg tablet by mouth as your doctor tells you. The dose and course are set by the doctor according to your condition and response, so do not change them yourself. Do not stop taking this medicine suddenly without medical advice, even if you feel well.
Side effects of RAMPRIL 1.25
Many people tolerate Ramipril well, but some feel dizzy, tired or weak, or get a headache. Rarely, more serious reactions such as swelling of the face and lips (angioedema) or high potassium levels may occur. Rarely, serious allergic reactions with swelling of the face or throat can occur. Tell your doctor promptly about any troublesome or unusual symptom, and seek urgent help for swelling of the face, lips or throat or trouble breathing.
Safety and precautions
Driving may be affected, especially with alcohol. It must not be taken during pregnancy, so pregnancy should be ruled out first, and it is not recommended while breastfeeding. Do not take RAMPRIL 1.25 1.25 mg tablet if you are pregnant, and pregnancy should be avoided during treatment; if you plan a pregnancy or become pregnant, contact your doctor so treatment can be changed. Keep out of reach of children.
Frequently asked questions
What is RAMPRIL 1.25 used for?
Only a doctor can decide if it is appropriate for a particular person. It is also used for congestive heart failure, sometimes with a diuretic.
How do I use RAMPRIL 1.25 correctly?
Swallow the tablet with water. RAMPRIL 1.25 is taken by mouth.
Can RAMPRIL 1.25 cause side effects?
Many people tolerate Ramipril well, but some feel dizzy, tired or weak, or get a headache. Rarely, more serious reactions such as swelling of the face and lips (angioedema) or high potassium levels may occur.
Can I use RAMPRIL 1.25 in pregnancy or while breastfeeding?
Driving may be affected, especially with alcohol. It must not be taken during pregnancy, so pregnancy should be ruled out first, and it is not recommended while breastfeeding.
Indications
- Hypertension; to lower blood pressure, as single-drug therapy or in combination with other antihypertensive agents.
- Congestive heart failure; also in combination with diuretics.
- Treatment of patients who- within the first few days after an acute myocardial infarction- have demonstrated clinical signs of congestive heart failure. ... Read more
- Hypertension; to lower blood pressure, as single-drug therapy or in combination with other antihypertensive agents.
- Congestive heart failure; also in combination with diuretics.
- Treatment of patients who- within the first few days after an acute myocardial infarction- have demonstrated clinical signs of congestive heart failure.
- Treatment of non-diabetic or diabetic overt glomerular or incipient nephropathy.
- Reduction in the risk of myocardial infarction, stroke, or cardiovascular death in patients with an increased cardiovascular risk, such as manifest coronary heart disease (with or without a history of myocardial infarction), a history of stroke, a history of peripheral vascular disease, or diabetes mellitus that is accompanied by at least one other cardiovascular risk factor (microalbuminuria, hypertension, elevated total cholesterol levels, low high-density lipoprotein cholesterol levels, smoking).
Pharmacology
Dosage & Administration
Hypertension: For the management of hypertension in adults not receiving a diuretic, the usual initial dose of Ramipril is 1.25-2.5 mg once daily. Dosage generally is adjusted no more rapidly than at 2 week intervals. The usual maintenance dosage in adults is 2.5-20 mg daily given as a single dose or in 2 divided doses daily. If BP is not controlled with Ramipril alone, a diuretic may be added.
Congestive heart failure after myocardial infarction: In this case, Ramipril therapy may be initiated as early as 2 days after myocardial infarction. An initial dose of 2.5 mg twice daily is recommended, but if hypotension occurs, dose should be reduced to 1.25 mg twice daily. Therapy is then titrated to a target daily dose of 5 mg twice daily.
Prevention of major cardiovascular events: In this case, the recommended dose is 2.5 mg once daily for the first week of therapy and 5 mg once daily for the following 3 weeks; dosage then may be increased, as tolerated, to a maintenance dosage of 10 mg once daily.
Dosage in renal impairment:
- For patients with hypertension and renal impairment: The recommended initial dose is 1.25 mg Ramipril once daily. Subsequent dosage should be titrated according to individual tolerance and BP response, up to a maximum of 5 mg daily.
- For patients with heart failure and renal impairment: The recommended dose is 1.25 mg once daily. The dose may be increased to 1.25 mg twice daily and up to a maximum dose of 2.5 mg twice daily depending upon clinical response and tolerability.
Interaction
Contraindications
- in patients with hypersensitivity to ramipril, to any other ACE inhibitor, or any of the excipients of Ramipril.
- in patients with a history of angioedema.
- concomitantly with sacubitril/valsartan therapy. Do not initiate Ramipril until sacubitril/valsartan is eliminated from the body. In case of switch from Ramipril to sacubitril/valsartan, do not start sacubitril/valsartan until Ramipril is eliminated from the body.
- in patients with haemodynamically relevant renal artery stenosis, bilateral or unilateral in the single kidney.
- in patients with hypotensive or haemodynamically unstable states.
- with aliskiren-containing medicines in patients with diabetes or with moderate to severe renal impairment (creatinine clearance <60 ml/min).
- with angiotensin II receptor antagonists (AIIRAs) in patients with diabetic nephropathy.
- during pregnancy.
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Management: Primary detoxifcation by, for example, gastric lavage, administration of adsorbents, sodium sulfate; (if possible during the frst 30 minutes). In the event of hypotension administration of α1-adrenergic agonists (e.g. norepinephrine, dopamine) or angiotensin II (angiotensinamide), which is usually available only in scattered research laboratories, must be considered in addition to volume and salt substitution.
Storage Conditions
Alternative brands of Ramipril
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.